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Abstract
Background: The use of functional genomics has largely increased our understanding of cell biology and promises
to help the development of systems biology needed to understand the complex order of events that regulates
cellular differentiation in vivo. One model system clearly dependent on the integration of extra and intra cellular
signals is the development of B-lymphocytes from hematopoietic stem cells in the bone marrow. This
developmental pathway involves several defined differentiation stages associated with specific expression of genes
including surface markers that can be used for the prospective isolation of the progenitor cells directly from the
bone marrow to allow for ex vivo gene expression analysis. The developmental process can be simulated in vitro
making it possible to dissect information about cell/cell communication as well as to address the relevance of
communication pathways in a rather direct manner. Thus we believe that B-lymphocyte development represents a
useful model system to take the first steps towards systems biology investigations in the bone marrow.
Results: In order to identify extra cellular signals that promote B lymphocyte development we created a database
with approximately 400 receptor ligand pairs and software matching gene expression data from two cell
populations to obtain information about possible communication pathways. Using this database and gene
expression data from NIH3T3 cells (unable to support B cell development), OP-9 cells (strongly supportive of B cell
development), pro-B and pre-B cells as well as mature peripheral B-lineage cells, we were able to identify a set of
potential stage and stromal cell restricted communication pathways. Functional analysis of some of these potential
ways of communication allowed us to identify BMP-4 as a potent stimulator of B-cell development in vitro. Further,
the analysis suggested that there existed possibilities for progenitor B cells to send signals to the stroma. The
functional consequences of this were investigated by co-culture experiments revealing that the co-incubation of
stromal cells with B cell progenitors altered both the morphology and the gene expression pattern in the stromal
cells.
Conclusions: We believe that this gene expression data analysis method allows for the identification of
functionally relevant interactions and therefore could be applied to other data sets to unravel novel
communication pathways.
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The development of mature blood cells from haemato-
poietic stem cells is a process involving a gradual loss of
multi-lineage potential and a subsequent gain of lineage
restricted cellular features. The maturation process is
reflected in surface marker expression allowing for sort-
ing of cells at defined stages of development and for
detailed functional and molecular analysis of stage speci-
fic events [1,2]. This has revealed that the differentiation
process is critically dependent on a set of transcription
factors that appears to act in a hierarchical and coordi-
nated manner to activate the correct genes and allow
the developmental pathway to proceed [3]. However, the
action of transcription factors and the outcome of the
developmental process are also highly dependent on
communication with other cells in the bone marrow
(BM) micro-environment [4,5]. One of the most care-
fully investigated developmental pathways in the BM is
the differentiation of B-lymphoid cells. The earliest B
cell progenitors are responsive to the stimulatory action
of the chemokine CXCL12 (SDF-1) [6,7] produced by
BM stromal cells [8], acting via the CXCR4 receptor on
the pro-B cells [9,10]. CXCL12 is produced by stromal
cells scattered in the BM, possibly creating a distinct
anatomical niche for the earliest stages of B-lymphoid
development [8]. These early cells are also supported by
the action of FL-ligand, that via the FLT-3 receptor
[11,12] stimulate lymphoid primed multipotent progeni-
tors (LMPPs [13]) to proceed into the lymphoid lineages
[14]. The subsequent developmental stage in B-lympho-
cyte development display a critical need for the cytokine
IL-7 and mice deficient in either the cytokine or the a
component (IL-7Ra) of the hetero-dimeric receptor, dis-
play disturbances in differentiation in both B and T lym-
phocyte development [15,16]. The phenotype observed
in these mice is further enhanced by the combined dis-
ruption of both the IL-7Ra and FL genes where the
block of B cell development is nearly complete [17,18].
It has been reported that ectopic expression of a second
ligand for the IL7Ra subunit, Thymic Stromal Lympho
Protein (TSLP) [19], can rescue the B-cell defects in IL-
7 deficient mice arguing for partially redundant func-
tions of IL-7 and TSLP [20]. However, mice deficient in
TSLP develop an apparently normal B-cell compartment
suggesting that the central factor in vivo is IL-7 [21].
Later stages of B cell development has been suggested
to be dependent on contact with supporting cells since
hematopoietic cells deficient in RANK ligand are
impaired in their ability to reconstitute the B220
+IgM
+
immature progenitor compartment upon transplantation
into wild type mice [22]. Thus, it is apparent that nor-
mal B-lymphopoiesis is dependent on communication
and contact between the developing cell and
surrounding cells like BM stroma cells [5]. Even if a set
of critical factors for normal development has been
identified, it is reasonable to presume that the cells are
exposed to a much larger number of signals that may
influence normal as well as malignant B-cell growth and
maturation.
In order to identify potential communication pathways
involved in the regulation of blood cell development, we
have developed a bioinformatic tool, Genomics based
Cell-cell Interaction analysis (GCINT) where gene
expression microarray data from two different cell types
can be used to unravel possible means of signaling in
the cellular interphase. The analysis is based on a data-
base containing verified receptor ligand pairs and a sec-
ond database that allows input of normalized gene
expression data from two different cell types. The data
is then analyzed so to unravel potential means of com-
munication based on matching expression of receptors
and ligands. This allowed us to identify novel potential
communication pathways, some of which were function-
ally investigated by in vitro differentiation of hemato-
poietic progenitors. In addition, the analysis revealed
that the presence of blood cells has a direct impact on
the gene expression of the stromal cells suggesting that
the interaction involve a complex two-way
communication.
Methods
GCINT analysis
GCINT is a database made in Microsoft Access, specia-
lized in matching known receptor-ligand interactions
using the locus link number from the microarrays. All
arrays used for GCINT analysis were normalized
together using RMA Express adding absent/present clas-
sification. Known receptor-ligand pairs identified by
NCBI http://www.ncbi.nlm.nih.gov and Genecards
http://www.genecards.org searches (Excel sheet in Addi-
tional file 1) were manually imported to the database. In
order to be processed by the database microarray data
have to contain: probe set, accession, description, inten-
sity values, absent/present call and gene name, in a text
file. In brief we have used affylmGUI [23] to RMA nor-
malized gene expression data and compared the gene
expression of each hematopoetic population with OP9
cells with P-value <0.01. The obtained gene lists was
then analyzed in GCINT to extract existing receptor-
ligands based on presence call in at least one popula-
tion. In order to compare the expression of relevant
genes in NIH3T3 and MC3T3 cells, the RMA normal-
ized expression values were extracted from dChip [24]
and inserted into the tables (Table 1, 2, 3, 4, 5, 6, 7 and
8a n da d d i t i o n a lf i l e s2 ,3 ,4 ,5 ,6 ,7 ,8a n d9 ) .G e n e
expression data from hematopoietic cells were collected
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GSE7302 and GSE11110) while gene expression data
from OP9 stroma cells, NIH3T3 fibroblasts and MC3T3
Osteoblasts were generated for this study and has been
deposited in GO (accession number GSE19729). The
M i r o s o f tA c e s sd a t a b a s ew i l lb ef r e e l ya v a i l a b l eu p o n
request.
Tissue culture conditions and cell lines
BAF3 cells were maintained in RPMI (PAA) supplemen-
ted with 10% fetal calf sera (FCS) (Hyclone), 10mM
HEPES (Gibco), 50 μM 2-mercaptoethanol (Gibco), 50
μg/ml Gentamicin (Invitrogen). The culturing media
was also supplemented with 5% conditioned media from
confluent WEHI3 cells, as source of interleukin-3. 230-
238 cells were grown in RPMI supplemented with 10%
FCS (Hyclone) and 50 μg/ml Gentamicin (Invitrogen).
FDC-P1 cells were maintained in Iscove’s Modified Dul-
becco’s Media (PAA) supplemented with 10% FCS
(Hyclone) 10% WEHI3 conditioned media and 50 μg/ml
Gentamicin (Invitrogen). NIH3T3 and MC3T3 cells
were propagated in Dulbecco’s Modified Eagle Medium
(Gibco) supplemented with 10% FCS (Hyclone) and 50
μg/ml Gentamicin (Gibco). OP9 and OP9 Strawberry
Table 1 Analysis of communication pathways for Long Term Hematopoietic Stem Cells (LT-HSC)
Gene expressed in LT-HSC Mean Intensity Corresponding gene in stroma Mean Intensity NIH3T3 Osteoblasts
activin receptor IIB 267 bone morphogenetic protein 4 1335 66 252
bone morphogenetic protein 4 169 bone morphogenetic protein receptor, type
1A
497 274 384
chemokine (C-X-C motif) receptor 4 372 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 149 epiregulin 422 288 153
insulin-like growth factor 2 105 insulin-like growth factor 2 receptor 535 1772 1704
Integrin alpha 4 1675 junction adhesion molecule 2 201 16 26
integrin beta 1 (fibronectin receptor
beta)
307 junction adhesion molecule 2 201 16 26
integrin beta 2 558 junction adhesion molecule 3 152 42 204
jagged 2 222 Notch gene homolog 3 (Drosophila) 367 161 48
oncostatin M 115 oncostatin M receptor 1151 1349 131
epidermal growth factor receptor 149 transforming growth factor alpha 261 13 21
Integrin alpha 4 1675 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
307 vascular cell adhesion molecule 1 692 182 929
integrin beta 7 329 vascular cell adhesion molecule 1 692 182 929
kinase insert domain protein receptor 311 vascular endothelial growth factor A 179 1006 169
Table 2 Analysis of communication pathways for Multipotent progenitors (MPP)
Gene expressed in MPP Mean Intensity Corresponding gene in stroma Mean Intensity NIH3T3 Osteoblasts
activin receptor IIB 183 bone morphogenetic protein 4 1335 66 252
Bone morphogenetic protein 15 413 bone morphogenetic protein receptor, type
1A
327 377 287
bone morphogenetic protein 4 112 bone morphogenetic protein receptor, type
1A
327 377 287
chemokine (C-X-C motif) receptor 4 264 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 231 epiregulin 422 288 153
insulin-like growth factor 2 271 insulin-like growth factor 2 receptor 535 1772 1704
interleukin 1 receptor, type I 123 interleukin 1 receptor antagonist 3515 16 10
integrin alpha 4 278 junction adhesion molecule 2 201 16 26
integrin beta 1 (fibronectin receptor
beta)
180 junction adhesion molecule 2 201 16 26
integrin beta 2 507 junction adhesion molecule 3 152 42 204
oncostatin M 157 oncostatin M receptor 1151 1349 131
epidermal growth factor receptor 231 transforming growth factor alpha 261 13 21
integrin alpha 4 278 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
180 vascular cell adhesion molecule 1 692 182 929
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Page 3 of 15were maintained in OptiMEM (Gibco) supplemented
with 10% FCS, 50 μg/ml Gentamicin (Invitrogen).
Adherent cells were treated with 0,1% Trypsin/EDTA
(Gibco) before passage. All cells were maintained in 37°
C5 %C O 2.
Isolation and purification of cells
Purification of LSK cells was performed as described in
[28]. Femur and tibia were taken from 10-16 week old
C57BL/6 mice, crushed to obtain suspension cells. BM
cells were enriched in KIT
+ (CD117+) cells using anti-
CD117 immuno magnetic beads (Miltenyi Biotechnol-
ogy) and separated in an Auto MACS column (Miltenyi
Biotechnology). BM cells were stained for Sca-1 Fitc
(EB-161.7), CD117 APC (2B8) and Linage PeCy5: CD3
(17A2), CD4 (GK1.5), Gr1 (RB6-8C5), CD19 (6D5),
Mac1(M1/70), NK.1(PK136) and Ter119 (Ter 119) (All
from Biolegend) after blocking unspecific binding by CD
16/32 (93) antibody (Biolegend). Sca
+ Kit
+ Lin
- cells
were sorted with BD FACS Aria Special Order System™.
Animals were housed in the animal facility at Linköping
University and the experiments were conducted
Table 3 Analysis of communication pathways for Lymphoid primed Multipotent Progenitors (LMPP)
Gene expressed in LMPP Mean
Intensity
Corresponding gene in stroma Mean
Intensity
NIH3T3 Osteoblasts
activin receptor IIA 131 bone morphogenetic protein 4 1335 66 252
activin A receptor, type 1 107 bone morphogenetic protein 4 1335 66 252
bone morphogenetic protein 4 277 bone morphogenetic protein receptor, type 1A 497 274 384
epidermal growth factor receptor 189 epiregulin 422 288 153
insulin-like growth factor 2 139 insulin-like growth factor 2 receptor 535 1772 1704
interleukin 2 receptor, gamma chain 2115 interleukin 7 189 92 255
oncostatin M 178 oncostatin M receptor 1151 1349 131
chemokine (C-X-C motif) receptor 4 290 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 189 transforming growth factor alpha 261 13 21
tumor necrosis factor 102 tumor necrosis factor receptor superfamily,
member 1a
1974 959 1143
tumor necrosis factor 102 tumor necrosis factor receptor superfamily,
member 1b
108 721 108
integrin alpha 4 268 vascular cell adhesion molecule 1 692 182 929
integrin beta 7 453 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
173 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
173 junction adhesion molecule 2 201 16 26
integrin alpha 4 268 junction adhesion molecule 2 201 16 26
integrin beta 2 484 junction adhesion molecule 3 152 42 204
Table 4 Analysis of communication pathways for Common Lymphoid Progenitors (CLP)
Gene expressed in CLP Mean Intensity Corresponding gene in stroma Mean Intensity NIH3T3 Osteoblasts
interleukin 2 receptor, gamma chain 3021 interleukin 7 189 92 255
chemokine (C-X-C motif) receptor 4 2121 chemokine (C-X-C motif) ligand 12 12222 23 798
integrin alpha 4 1982 vascular cell adhesion molecule 1 692 182 929
integrin alpha 4 1982 junction adhesion molecule 2 201 16 26
integrin beta 2 920 junction adhesion molecule 3 152 42 204
Bone morphogenetic protein 15 645 bone morphogenetic protein receptor, type 1A 497 274 384
chemokine (C-C motif) receptor 9 443 chemokine (C-C motif) ligand 25 123 55 100
insulin-like growth factor 2 282 insulin-like growth factor 2 receptor 535 1772 1704
epidermal growth factor receptor 193 epiregulin 422 288 153
epidermal growth factor receptor 193 transforming growth factor alpha 261 13 21
interleukin 1 receptor, type I 180 interleukin 1 receptor antagonist 3515 16 10
activin receptor IIB 166 bone morphogenetic protein 4 1335 66 252
interleukin 1 receptor, type II 127 interleukin 1 receptor antagonist 3515 16 10
oncostatin M 112 oncostatin M receptor 1151 1349 131
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from Linköping ethical committee.
Generation of Strawberry fluorescent OP9
mStrawberry vector was kindly provided by Dr R.
Tsien UCSD. The mStrawberry gene was cloned
between the BamH1 and EcoR1 sites in a pBabe-
Puro vector. In order to produce retrovirus, pBabe
Strawberry encoding plasmid was transfected in to
Phoenix packaging cells using Lipofectin (Invitrogen).
Transfected cells were selected in 2 μg/ml puromycin
(Sigma Aldrich) for 1 week. Viral supernatant were
collected and used for infection of OP9 cells by
incubation for 8 hours in the presence of 0,5 ug/ml
polybren (Sigma Aldrich). Infected OP9 cells were
sorted for high expression of Strawberry detected by
FACS Aria Special Order™ System using TxRed
channel.
Table 5 Analysis of communication pathways for Granolocyte Monocyte Progenitors (GMP)
Gene expressed in GMP Mean Intensity Corresponding gene in stroma Mean Intensity NIH3T3 Osteoblasts
chemokine (C-X-C motif) receptor 4 768 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 182 epiregulin 422 288 153
interleukin 2 receptor, gamma chain 869 interleukin 7 189 92 255
integrin alpha 4 171 junction adhesion molecule 2 201 16 26
integrin beta 1 (fibronectin receptor beta) 122 junction adhesion molecule 2 201 16 26
integrin beta 2 969 junction adhesion molecule 3 152 42 204
epidermal growth factor receptor 182 transforming growth factor alpha 261 13 21
integrin alpha 4 171 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor beta) 122 vascular cell adhesion molecule 1 692 182 929
neuropilin 1 120 vascular endothelial growth factor A 179 1006 169
neuropilin 1 120 vascular endothelial growth factor B 174 191 639
Table 6 Analysis of communication pathways for progenitor B-cells (Pro-B)
Gene expressed in ProB Mean
Intensity
Corresponding gene in stroma Mean
Intensity
NIH3T3 Osteoblasts
activin receptor IIA 139 bone morphogenetic protein 4 1335 66 252
activin receptor IIB 178 bone morphogenetic protein 4 1335 66 252
CD28 antigen 439 CD80 antigen 462 38 71
epidermal growth factor receptor 193 Epiregulin 422 288 153
insulin-like growth factor 2 113 insulin-like growth factor 2 receptor 535 1772 1704
interleukin 2 receptor, gamma chain 3348 interleukin 7 189 92 255
L1 cell adhesion molecule 596 neural cell adhesion molecule 1 129 740 545
oncostatin M 143 oncostatin M receptor 1151 1349 131
platelet derived growth factor, B
polypeptide
122 platelet derived growth factor receptor, alpha
polypeptide
2140 1066 445
platelet derived growth factor, B
polypeptide
122 platelet derived growth factor receptor, beta
polypeptide
1829 505 1782
chemokine (C-C motif) receptor 2 141 chemokine (C-C motif) ligand 2 239 3362 362
chemokine (C-C motif) receptor 9 376 chemokine (C-C motif) ligand 25 123 55 100
chemokine (C-X-C motif) receptor 4 702 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 193 transforming growth factor alpha 261 13 21
integrin alpha 4 413 vascular cell adhesion molecule 1 692 182 929
integrin beta 7 2879 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
130 vascular cell adhesion molecule 1 692 182 929
neuropilin 1 333 vascular endothelial growth factor A 275 1872 387
kinase insert domain protein receptor 389 vascular endothelial growth factor A 275 1872 387
integrin beta 1 (fibronectin receptor
beta)
130 junction adhesion molecule 2 201 16 26
integrin alpha 4 413 junction adhesion molecule 2 201 16 26
integrin beta 2 4429 junction adhesion molecule 3 152 42 204
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15 000 OP9 or 20 000 NIH3T3 cells were suspended in
1 ml optiMEM (Gibco) supplemented with 10% FCS
(Hyclone), 25 mM HEPES (Gibco), 50 μg/ml Gentami-
cin (Gibco) 50 μM 2-mercaptoethanol (Gibco) and
seeded into each well of a 24 well plate. LSK cells were
sorted, suspended in optiMEM (Gibco) supplemented
with 10% FCS (Hyclone), 25 mM HEPES (Gibco), 50
μg/ml Gentamicin (Gibco) 50 μM 2-mercaptoethanol
(Gibco) at a density of 100 cells/ml. This cell suspension
was used to replace the medium in the wells containing
OP9 or NIH3T3 cells that within 4 hours adhere to the
bottom of the wells to form a feeder layer. The cultures
were then supplemented with cytokines IL-7, FL, (Both
at a concentration of 10 ng/ml) CXCL12, (All from
Peprotech) BMP4, IL1ra (All at a concentration of 30
ng/ml) (Both from Prospec) as indicated. Cells were
maintained in 37°C 5% CO2 for 7 days, where after 50%
of the upper layer of media was replaced and 1 ml of
new cytokine containing media were added. At day 14
suspension cells were gently removed from the wells to
be stained with B220 PE (RA36B2) (BecktonDickinson),
CD19 PECy5 (6D5), Mac1 FITC (M/70) (All from Biole-
gend), analyzed on FACS Calibur (BecktonDickinson).
T h ef l o wd a t aw a sf u r t h e ra n a l y z e dw i t ht h eF l o w J o
(Tree star Incorparated) software.
Microarray analysis
RNA was prepared using RNeasy mini kit with DNase
treatment of the column (Qiagen). Concentration of
Table 7 Analysis of communication pathways for pre-B cells (pre-B)
Gene expressed in PreB Mean Intensity Corresponding gene in stroma Mean Intensity NIH3T3 Osteoblasts
chemokine (C-X-C motif) receptor 4 1526 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 177 Epiregulin 422 288 153
interleukin 2 receptor, gamma chain 2147 interleukin 7 189 92 255
integrin alpha 4 199 junction adhesion molecule 2 201 16 26
integrin beta 2 1438 junction adhesion molecule 3 152 42 204
oncostatin M 101 oncostatin M receptor 1151 1349 131
epidermal growth factor receptor 177 transforming growth factor alpha 261 13 21
integrin alpha 4 199 vascular cell adhesion molecule 1 692 182 929
Table 8 Analysis of communication pathways for mature B-cells (B-cells)
Gene expressed in MatureB Mean
Intensity
Corresponding gene in stroma Mean
Intensity
NIH3T3 Osteoblasts
chemokine (C-X-C motif) receptor 4 1275 chemokine (C-X-C motif) ligand 12 12222 23 798
epidermal growth factor receptor 145 Epiregulin 422 288 153
interleukin 2 receptor, gamma chain 2746 interleukin 7 189 92 255
Integrin alpha 4 1640 junction adhesion molecule 2 201 16 26
integrin beta 1 (fibronectin receptor
beta)
235 junction adhesion molecule 2 201 16 26
integrin beta 2 1781 junction adhesion molecule 3 152 42 204
lymphotoxin A 540 lymphotoxin B receptor 965 285 519
transforming growth factor, beta 1 718 Similar to Ornithine decarboxylase (ODC) 197 146 14
epidermal growth factor receptor 145 transforming growth factor alpha 261 13 21
transforming growth factor, beta 1 718 transforming growth factor, beta receptor II 171 85 253
transforming growth factor, beta 1 718 transforming growth factor, beta receptor III 3653 3429 1152
lymphotoxin A 540 tumor necrosis factor receptor superfamily,
member 1a
1974 959 1143
lymphotoxin A 540 tumor necrosis factor receptor superfamily,
member 1b
108 721 108
Integrin alpha 4 1640 vascular cell adhesion molecule 1 692 182 929
integrin beta 1 (fibronectin receptor
beta)
235 vascular cell adhesion molecule 1 692 182 929
integrin beta 7 942 vascular cell adhesion molecule 1 692 182 929
Tables 1, 2, 3, 4, 5, 6, 7 and 8. Receptor ligand pairs identified as possible means of communication between a model stroma cell line OP9 and sorted
hematopoietic cells from the mouse bone marrow. Expression values observed in fibroblastic NIH3T3 and osteoblastic MC3T3 cells are included to allow for the
identification of stromal cell specific interactions. The diagram only display receptor ligand pairs were genes on the hematopoietic array as well as of the stromal
cells arrays have a normalized expression value above 100. Full lists of potential interactions can be found in Additional files 2, 3, 4, 5, 6, 7, 8 and 9. For sorted
cells as well as OP9 the value is a mean out of 2 experiments for complete list of genes for each cell type see Additional files 2, 3, 4, 5, 6, 7, 8 and 9.
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RIN value were estimated on the Bioanalyzer (Agilent™).
RNA was labeled and amplified according to Affyme-
trix™ GeneChip Expression Analysis Technical Manual,
and hybridized to GeneChip Mouse Genome 430 2.0
Array. Chips were scanned using Affymetrix GeneChip™
Scanner. The data were analyzed using dChip http://
www.dchip.org software.
Gene Expression analysis using real time quantitative PCR
RNA was extracted from sorted OP9 mStrawberry cells
as described above. cDNA was generated by annealing 1
μg of total RNA in1,5 mM random hexamer, 5× first
strand buffer,100 mM DTT, 5 mM dNTP, 40U RNAse
out, 200U superscript III (All from Invitrogen), in a
total volume of 20 μl. Real time qPCR was conducted
with TaqMan™ technology (Applied Biosystems), the
threshold cycles for the endogenous control was set to
0,05. All experiments were conducted in triplicates and
normalized against HPRT expression. 2
ΔΔCT was calcu-
lated as follows, where G.O.I indicates gene of interest
ΔΔCT =( C TG.O.I (control)-H P R T )-( C TG.O.I (sample) -
HPRT) Control were cells in parallel culture with condi-
tioned media from co-culture sample. Oligonucleotides
for quantitative TaqMan real time PCR; Hprt: Mm
00446968_m1, Spib:Mm 01719550_s1, Nov: Mm
00456855_m1, Cxcl10: Mm 00445235_m1 was ordered
from AppliedBiosystems™.
Results
Genomics Based Cell Interaction (GCINT) analysis allows
for a rapid analysis of potential receptor/ligand
involvement in the communication between two cell
types
The communication between two cells like the B cell pro-
genitors and the stromal cells is likely to involve a highly
complex set of interactions driving proliferation and differ-
entiation of the hematopoietic cells. In order to get a more
complete picture over the possible communication path-
ways during differentiation of B-lineage cells, we created a
database with information about 400 known receptor
ligand pairs using GeneCards http://www.genecards.org as
our major source of information (Excel sheet attached as
Additional file 1). The involved gene products were
coupled to their locus link number and further to Affyme-
trix Mouse Genome 430 2.0 Array probe sets. This data-
base was created so to allow for the match of two
microarray data sets to unravel potential pathways of com-
munication between the two cell types represented by the
array data. GCINT show the gene names, intensity values
for the probe sets, locus link accessions and descriptions
for the two matched arrays. These values can then be cop-
ied to an excel sheet for further analysis. The simplicity of
this method allows for investigations of rather large data
sets to gain insight to the dynamics of cell-cell communi-
cation during biological processes such as development. In
order to investigate temporal changes in communication
during the path of B-cell development, we sorted and
extracted gene expression information by microarray ana-
lysis from a variety of hematopoietic progenitor cells in
the mouse BM. Long-term hematopoietic stem cells (LT-
HSCs) were sorted based on low expression of lineage
markers (Lin
-) (Please see materials and methods for
details) and expression of SCA1 and KIT (LSK) but lack of
surface expression of CD34 and FLT3 [13,29]. Multipotent
progenitors (MPP) were sorted based on a LSKCD34
+FLT3
- phenotype while Lymphoid primed multipotent
progenitors (LMPPs) were defined as LSK cells with
expression of both CD34 and FLT3 [13,29]. Granulocyte/
Monocyte progenitors (GMP) was sorted based on expres-
sion of CD34, KIT and FCg RII/III [30,31] while Common
lymphoid progenitors (CLPs) lack the expression of line-
age markers, has reduced levels of KIT and SCA as com-
pared to the multipotent progenitors and express IL-7
receptor on the cell surface [32]. The earliest B-lineage
restricted progenitors (pro-B) were sorted based on a
B220
+ CD43
+ CD19
+ IgM
- surface phenotype while pre-B
cells were defined as B220
+ CD43
- CD19
+ IgM
-cells from
mouse bone marrow and mature B-cells as CD19
+ IgM
+
cells from mouse spleen [33]. For all the populations RNA
was extracted and subjected to two rounds of linear ampli-
fication where after the resulting cRNA was hybridized to
a UA430_2 Affymetrix™ oligonucleotidearrays. In order to
obtain gene expression information from a relevant
mesenchymal cell, we used the same micro-arrays to ana-
lyze the gene expression pattern in OP9 stromal cells, with
ability to support B-cell development in vitro,a n d
NIH3T3 cells, a fibroblast unable to perform this task
under our standard conditions (Figure 1). In addition we
included gene expression data from the osteoblast cell line
MC3T3, representing a third type of BM cell. The output
of the GCINT analysis will be highly dependent on the
gene lists imported to the program. This creates a large
flexibility and opens the possibility to create the gene list
used for analysis in a way suitable for the scientific ques-
tion at hand. In our specific case, we aim to identify fac-
tors secreted by stroma cells that may effect the
maturation of B-lymphoid cells. Therefore we made the
presumption that genes encoding crucial growth factors
secreted by stroma cells, would not be expressed by the
hematopoetic cells themselves. We then used RMA nor-
malized data from OP9 cells and hematopoetic progeni-
tors and select genes based on differential gene expression
(p < 0-01) in the different cell types (Please see Materials
and Methods for details). This generated one list of genes
for each hematopoietic population. These lists were
imported into GCINT and receptor ligand pairs were
extracted. This revealed several possibilities for
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tors and the stromal cells (Table 1, 2, 3, 4, 5, 6, 7, 8 and
A d d i t i o n a lf i l e s2 ,3 ,4 ,5 ,6 ,7 ,8a n d9 ) .S o m er e c e p t o r
ligand pairs such as Integrina 4-VCAM1 were expressed
at all stages of hematopoietic development while others
were more restricted to defined stages of differentiation.
Thus, a genomics based analysis provides information
about potential stage specific interactions between hema-
topoietic progenitors and stromal cells.
BMP4 and support B-cell development in vitro
Knowing that our analysis extracted information about
potential stage specific cell interactions, we wanted to
investigate if this approach allowed for the identification
of B-lineage growth factors. To this end, we develop an
experimental system based on two functionally different
support cells differing in their ability to support the
development of B-lineage cells from immature hemato-
poietic progenitor cells. Such a model system allow us
to compare gene expression patterns in the two cell
lines to identify genes associated with an ability to sup-
port B-cell development. Further, this opens the possibi-
lity to functionally investigate the role for the identified
factors by the addition of the potentially involved pro-
teins in co-culture experiments. The stromal cell line
OP9 is known to be a powerful stimulator of B-cell
development in vitro so as a control, we used standard
growth conditions for immature LSK cells on OP9 cells
Figure 1 Differential ability of OP9 and NIH3T3 cells to stimulate B-cell development from hematopoetic progenitor cells.
Representative FACS plots of the cells generated after 14 days of incubation of 100 LSK cells on OP9 or NIH3T3 cells with the indicated addition
of cytokines. The cells were analyzed with regard to the expression of CD19, B220, and MAC1 as indicated in the diagrams. The numbers in the
panels represents average percentages of different cell subsets obtained under the defined conditions after analysis of at least three
independent experiments.
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Page 8 of 15with optiMEM supplemented with FCS. Cultivation of
LSK cells on OP9 resulted in a high percentage of CD19
+B220
+ cells (Figure 1 (OP9) and Figure 2) and even
though the addition of FL and IL7 did not have a major
impact of the cellular composition of the cultures (Fig-
ure 1 (OP9+FL+IL7)), the cell numbers were increased
(Data not shown). In contrast, without the addition of
any cytokines, more than 50% of the hematopoietic cells
g e n e r a t e do nN I H 3 T 3c e l l se x p r e s s e dM A C 1( F i g u r e1
(3T3)) indicating that they had developed into myeloid
lineage cells. A few B220
+ but no CD19
+ cells, repre-
senting the committed progenitors [33], were detected.
This suggests that NIH3T3 cells are unable to support
the development of CD19
+ B-lymphoid cells from multi-
potent hematopoietic progenitors. The two cytokines
FLT3 and IL7 has been shown able to allow for B-line-
age development from LSK cells in vitro [34] and the
inclusion of these growth factors into the NIH3T3/LSK
co-cultures resulted in an increased percentage of B220
+
cells and also generation of CD19
+ cells (Figure 1 (3T3
+FL+IL7)). These experiments suggested that OP9 cells
but not NIH3T3 cells express factors that are involved
in the generation of B-lymphoid cells from multipotent
progenitor cells. We next used our receptor ligand ana-
lysis in order to identify genes encoding growth factors
that were differentially expressed in OP9 and NIH3T3
cells and were mRNA coding for a receptor was
expressed in early progenitors and B-lineage cells. One
factor exclusively expressed in OP9 cells, was CXCL12
presumably interacting with the CXCR4 receptor on the
B-lineage cells (Table 6 and 7). This factor has been
suggested to stimulate B cell development and growth
[6,7], however, in our experimental setting, this factors
was unable to support development of CD19
+ cells from
multipotent progenitors to any significantly higher level
than FL and IL-7 (Figure 1 (3T3+FL+IL7+CXCL12) and
Figure 2). A second cytokine, BMP4, with a possibility
to interact with the BMPR on the pro-B cells, was
expressed to a higher level in the OP9 cells as compared
to NIH3T3 cells. In contrast to CXCL12, the addition of
BMP4 resulted in an increased formation of both CD19
+ and CD19
+ B220
+ cells as compared to the FL and IL7
stimulated control cultures (p < 0,001)(Figure 1
(NIH3T3+FL+IL7+BMP4) and Figure 2). Thus, this
approach allows for the identification of novel growth
factors involved in the development of B-lymphoid cells.
Contact with hematopoietic cells modulates gene
expression patterns in the stromal cells
Another possibility created by this type of data analysis
is to investigate any apparent directionality of communi-
cation and even though the analysis of the pro-B/OP9
interaction suggests that the majority of the information
flow is from the stroma to the hematopoietic cell, there
exist several possibilities for communication in the
opposite direction. In order to investigate if hematopoie-
tic cells would be able to induce a cellular response in
stromal cells, we incubated either in vitro expanded pri-
mary B-cell progenitors or a pre-B cell line with OP9
stromal cells for 7 days. This revealed that co-incubation
with either transformed B-cell lines (Data not shown) or
primary Pro-B cells generated by in vitro differentiation
of LSK cells, resulted in a change of morphology of the
stromal cells (Figure 3A,B). This effect was not detected
when OP9 cells were incubated with conditioned media
from a parallel co-culture experiment suggesting that
this was not due to alterations in nutrient concentra-
tions in the media or due to secreted factors but a result
of cell-cell contact or proximity. The control culture
contained big, rounded cells while the OP9s incubated
with B-lineage progenitors had adapted a different mor-
phology with elongated cells (Figure 3A,B). These data
suggest that the B-cell progenitor cells were able to
modulate the morphological characteristics of the OP9
stromal cells. In order to investigate this further, we
wanted to extract RNA from the stromal cells in the co-
culture and the corresponding control culture. This
experiment was complicated by that the B-cell progeni-
tors attached firmly to the OP9 cells demanding trypsin/
EDTA treatment of the cells in order to generate the
homogenous single cell suspension needed to separate
the OP9 cells from the hematopoietic cells. Treament
with trypsin/ETDA reduces the possibility to sort cells
by Flow Cytometry based on cell surface marker expres-
sion. Hence, in order to be able to purify the OP9 cells
for molecular analysis, we did a retroviral infection of
OP9 cells with the red fluorescent protein - mStraw-
berry [35]) (OP strawberry, (OP9S)). This allowed us to
sort out the red stromal cells (Figure 3C) and separate
them from the hematopoietic cells in order to investi-
gate potential changes in gene expression patterns in
the OP9 cells. To this end, we incubated OP9S cells
with 230-238 pre-B cells for 7 days and the gene expres-
sion pattern was compared to that of cells obtained by
parallel incubation with the conditioned media by
microarray analysis (Figure 3D). This suggested that sev-
eral genes in the stromal cells were induced by the
direct contact with the B-cell progenitor cell line while
another set of genes were expressed at a lower level in
the co-cultured OP9 cells. Among the genes induced by
the pre-B cells were several chemokine genes including
Ccl-2, -5, -9 as well as the hematopoietic growth factor
Nephrobastoma overexpressed protein (NOV) [36]. We
could also detect differentiale x p r e s s i o no fan u m b e ro f
transcription factors including the ets transcription fac-
tor SpiB. In order to verify the induction of some genes
and to investigate potential differences in the response
dependent of the hematopoietic cell type used for co-
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Page 9 of 15culture, we performed Q-PCR from sorted OP9S cells
incubated for 7 days with pre-pro B cells (BaF3), pre-B
cells (230-238) or the myeloid progenitor cell line FDC-
P1. Incubation with BaF3 cells resulted in up-regulation
of Nov, Spi-B as well as Cxcl10 message (Figure 4A) and
even if the level of induction was varying between differ-
ent experiments (Data not shown), these changes were
consistently detected. The same induction pattern was
observed using 230-238 pre-B cells (Figure 4B) while the
response to the myeloid progenitor cell line FDC-P1
cells differed in that even though a dramatic induction
in Cxcl10 mRNA could be detected, the expression of
SpiB or Nov message was not increased (Figure 4C).
This indicates that the response of the OP9S cells may
vary dependent on the cell type used for the co-culture
experiment suggesting that different hematopoietic cells
m a yi n d u c es p e c i f i cg e n ee x p r e s s i o np a t t e r n si ns t r o m a
cells.
Discussion and Conclusions
We here report of how gene expression data can be
used to identify molecules involved in cellular synapses.
This type of analysis is most helpful for the understand-
ing of complex systems in which cell-cell contact is cru-
cial for the function or development of cells. Our
analysis using data from a model stromal cell line and
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Figure 2 BNP4 stimulates B-cell development from early bone marrow progenitor cells. Diagrams displaying the cellular composition of
cultures as judged by FACS analysis of B220, CD19 and MAC-1 surface expression obtained by in vitro differentiation of 100 LSK cells. The
progenitors were incubated for 14 days with either OP9 or NIH3T3 cells and the indicated cytokines. Each dot in the diagrams represents one
well and data are collected from at least three independent experiments (n = 13-18). Line indicates the average of all the analyzed wells and the
P values has been calculated as compared to the cellular composition obtained on NIH3T3 cells with the addition of FL and IL7.
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Page 10 of 15Figure 3 B-cell progenitors modulate the behavior of OP9 stromal cells in vitro. Panel (A-B) display pictures of OP-9 cells grown in parallel
cultures with either conditioned media (A) or in direct contact with pro-B cells (B) generated by in vitro differentiation of LSK cells. The pictures
are taken from the same six well tissue culture plates with 200 times amplification and under the same light conditions (Leica DFC290). The
black bar indicates 100 μM. Panel (C) shows a representative sorting experiment where trypsin/EDTA treated co-cultures of OP9S and pro-B cells
are separated based on forward scatter and Strawberry expression. Panel (D) display a cluster analysis of RMA normalized gene expression
patterns in OP9S cells incubated with either conditioned media or the pre-B cell line 230-238. The analysis displays genes with an expression
level above 100 and with at least 5-fold difference in expression in the two experiments with P-value < 0.05. Red indicates high and blue low
expression.
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Page 11 of 15primary hematopoietic cell populations representing dif-
ferent lineages and developmental stages, suggests that
even though several communication pathways are
shared, we were able to identify potential stage and line-
age restricted pathways that may be involved in events
such as lineage restriction. Some of these involve known
factors such as the IL-7 and CXCL12 pathways, both
reported to be important for B cell development
[7,15,16,37-39] but the approach taken also allows for
the identification of novel factors of potential interest.
The methodology opens for a possibility to identify
cytokines or surface proteins involved in the regulation
of hematopoiesis through comparative analysis of gene
expression patterns in functionally different support
cells. In this paper we report of such an analysis using
fibroblastic NIH3T3 cells, unable to support B-lymphoid
development from multipotent progenitor cells, and
OP9 cells that are supportive of this process. This
allowed us to identify two factors expressed by OP9 but
not NIH3T3 cells. Among these has CXCL12 previously
been reported to stimulate B cell growth and develop-
ment [6,7], however, in our co-culture system, the sec-
ond candidate, BMP4, were the more potent stimulator
of B-cell development (Figure 2). A role for BMP4 in
hematopoiesis was has been suggested from studies in
xenopus embryos as this factor is important for the spe-
cification of the first hematopoietic progenitors [40,41].
BMP4 has also been shown to stimulate embryonal
stem cells from both mouse [42] and humans [43] to
undergo development into hematopoietic lineages. BMP
proteins have also been shown to stimulate the growth
of primitive human hematopoietic stem cells [44]
arguing for a functional role on stem cell expansion.
Our data suggest that BMP4 also possess the ability to
stimulate development of adult progenitors into B-lym-
phoid cells. We have not investigated the mechanisms
involved in effects of BMP4 or selective abilities of the
investigated cytokines to support development and
expansion of specific cell types but our findings suggest
that our genomics approach reveals relevant functional
interactions.
The normal BM stroma is composed of a large variety
of cell types with potentially highly specific functions in
the regulation of hematpoiesis. In these initial studies
we have used a model stromal cell line, OP9, with a
high potential to stimulate B-lymphocyte development.
This has allowed us to obtain ideas about signaling
pathways in the bone marrow, however, in order to
fully understand the signaling processes we would need
to investigate relevant primary stroma cells from mouse
BM. The BM is thought to be organized into anatomi-
cal niches harboring blood cells of specific developmen-
tal stages and possibly lineages. The most immature
cells has been suggested to reside in the endosteum
where osteoblasts presumably are involved in the regu-
lation and maintenance of the stem cell pool while
more mature cells reside closer to the central region of
the bone marrow cavity [4,45-47]. In the case of B-cell
progenitors, it has been suggested that they reside in
close contact with adventitial reticular cells near to the
BM capillaries [8]. Interestingly, it does not appear as if
the same stromal cells produce both CXCL12 and IL-7
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Figure 4 Co-culture of cell lines representing different
hematopoietic lineages induces differential gene expression
patterns in OP9 cells. The diagrams display HPRT normalized Q-
PCR data from OP9S cells generated by co-incubation of
hematopoietic cell lines or filtered media from the parallel co-culture
experiments (OP9S). The expression pattern in the control cells were
set to one for each of the Nov (Black bar), SpiB (White bar) or Cxcl10
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bars indicate experimental variation in one out of two or three
experiments.
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Page 12 of 15but that these cytokoines rather are produced by differ-
ent cells [8]. Thus, in order for the B-cell progenitor to
obtain the proper stage specific signals there would
exist need for a movement of the developing cells in
the BM. This could well be one of the driving forces of
cell maturation and niche organization, however, our
data suggesting that the stromal cells respond to signals
from the hematopoietic cells opens for an alternative or
possibly complementary explanation where the cells
that in direct contact with the stromal cell stimulates
activation of a certain cytokine profile. As the cell
mature, the signals from the developing cell changes
resulting in new instructions to the stromal cells creat-
ing a dynamic system where the progenitors and the
stroma directly communicates in order to drive the
development of a hematopoietic cell as well as the
stroma. In this scenario there would exist plasticity
within a certain niche to ensure that all progenitors that
enter the compartment are driven to differentiation.
Such mechanism could operate on a single cell level,
h o w e v e r ,s i n c ea n yg i v e ns t r o m a lc e l li sl i k e l yt ob ei n
contact with several progenitor cells at a given time,
this would require a synchronized differentiation pro-
cess and an ability of the stromal cell to return to a
ground stage when the hematopoietic cells have left to
enter another developmental niche. However, there
exist a large need to investigate the plasticity of primary
stromal cells or potentially mesenchymal stem cells
(MSCs) from the BM. MSCs are multipotent cells cap-
able to differentiate along several pathways to produce
for instance adipocytes, chondrocytes and osteoblasts in
vitro [48]. The different cell fates can be regulated
through modifications of tissue culture conditions and
it has been reported that HSCs have an ability to induce
osteoblast differentiation of multipotent mesenchymal
stem cells, thus contributing to the creation of the stem
cell niche [49].
Even if the information generated by genomics based
cell interaction analysis represents an approximation, we
believe that we have been able to show that this
approach allows for the generation of biologically rele-
vant and useful information. The development of proto-
cols that allows for the purification of specific stromal
cell populations directly from the bone marrow will
allow us to feed even more relevant information into
the program and thereby increase our possibilities to
identify novel stage and lineage specific cell-cell commu-
nication pathways in vivo.
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